Annual EBITDA
-$48.06 M
+$23.07 M+32.43%
December 31, 2023
Summary
- As of March 10, 2025, MBIO annual EBITDA is -$48.06 million, with the most recent change of +$23.07 million (+32.43%) on December 31, 2023.
- During the last 3 years, MBIO annual EBITDA has risen by +$6.25 million (+11.51%).
- MBIO annual EBITDA is now -317.72% below its all-time high of -$11.51 million, reached on December 31, 2016.
Performance
MBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.36 M
+$6.84 M+83.43%
September 30, 2024
Summary
- As of March 10, 2025, MBIO quarterly EBITDA is -$1.36 million, with the most recent change of +$6.84 million (+83.43%) on September 30, 2024.
- Over the past year, MBIO quarterly EBITDA has stayed the same.
- MBIO quarterly EBITDA is now -106.38% below its all-time high of -$658.00 thousand, reached on September 30, 2015.
Performance
MBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$22.30 M
+$8.33 M+27.19%
September 30, 2024
Summary
- As of March 10, 2025, MBIO TTM EBITDA is -$22.30 million, with the most recent change of +$8.33 million (+27.19%) on September 30, 2024.
- Over the past year, MBIO TTM EBITDA has stayed the same.
- MBIO TTM EBITDA is now -3289.51% below its all-time high of -$658.00 thousand, reached on September 30, 2015.
Performance
MBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MBIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.4% | 0.0% | 0.0% |
| 3 y3 years | +11.5% | 0.0% | 0.0% |
| 5 y5 years | -60.1% | 0.0% | 0.0% |
MBIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.4% | at high | +93.0% | at high | +69.4% |
| 5 y | 5-year | -11.1% | +32.4% | at high | +93.3% | at high | +69.4% |
| alltime | all time | -317.7% | +32.4% | -106.4% | +93.3% | -3289.5% | +69.4% |
Mustang Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.36 M(-83.4%) | -$22.30 M(-27.2%) |
| Jun 2024 | - | -$8.20 M(+82.4%) | -$30.63 M(-19.2%) |
| Mar 2024 | - | -$4.49 M(-45.6%) | -$37.90 M(-21.1%) |
| Dec 2023 | -$48.06 M(-32.4%) | -$8.26 M(-14.8%) | -$48.06 M(-16.3%) |
| Sep 2023 | - | -$9.69 M(-37.3%) | -$57.45 M(-11.5%) |
| Jun 2023 | - | -$15.46 M(+5.5%) | -$64.90 M(-3.0%) |
| Mar 2023 | - | -$14.66 M(-16.9%) | -$66.91 M(-5.9%) |
| Dec 2022 | -$71.14 M(+11.1%) | -$17.64 M(+2.9%) | -$71.14 M(-2.4%) |
| Sep 2022 | - | -$17.14 M(-1.8%) | -$72.85 M(+1.0%) |
| Jun 2022 | - | -$17.46 M(-7.5%) | -$72.09 M(+5.3%) |
| Mar 2022 | - | -$18.89 M(-2.4%) | -$68.47 M(+6.9%) |
| Dec 2021 | -$64.05 M(+17.9%) | -$19.35 M(+18.1%) | -$64.05 M(-1.2%) |
| Sep 2021 | - | -$16.39 M(+18.4%) | -$64.81 M(+11.3%) |
| Jun 2021 | - | -$13.84 M(-4.3%) | -$58.24 M(+0.5%) |
| Mar 2021 | - | -$14.46 M(-28.1%) | -$57.92 M(+6.6%) |
| Dec 2020 | -$54.31 M | -$20.12 M(+105.0%) | -$54.31 M(+9.9%) |
| Sep 2020 | - | -$9.81 M(-27.5%) | -$49.42 M(+1.1%) |
| Jun 2020 | - | -$13.53 M(+24.7%) | -$48.86 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$10.85 M(-28.7%) | -$44.82 M(+3.6%) |
| Dec 2019 | -$43.25 M(+44.1%) | -$15.22 M(+64.5%) | -$43.25 M(+9.6%) |
| Sep 2019 | - | -$9.26 M(-2.5%) | -$39.48 M(+5.2%) |
| Jun 2019 | - | -$9.49 M(+2.2%) | -$37.55 M(+13.7%) |
| Mar 2019 | - | -$9.28 M(-18.9%) | -$33.03 M(+10.0%) |
| Dec 2018 | -$30.02 M(-4.0%) | -$11.45 M(+56.4%) | -$30.02 M(-11.2%) |
| Sep 2018 | - | -$7.32 M(+47.0%) | -$33.79 M(+0.7%) |
| Jun 2018 | - | -$4.98 M(-20.7%) | -$33.56 M(-2.0%) |
| Mar 2018 | - | -$6.27 M(-58.8%) | -$34.24 M(+9.8%) |
| Dec 2017 | -$31.28 M(+171.8%) | -$15.22 M(+114.9%) | -$31.19 M(+30.3%) |
| Sep 2017 | - | -$7.08 M(+25.0%) | -$23.94 M(+29.2%) |
| Jun 2017 | - | -$5.67 M(+76.2%) | -$18.52 M(+33.3%) |
| Mar 2017 | - | -$3.22 M(-59.7%) | -$13.90 M(+20.8%) |
| Dec 2016 | -$11.51 M | -$7.98 M(+378.2%) | -$11.51 M(+163.1%) |
| Sep 2016 | - | -$1.67 M(+60.4%) | -$4.37 M(+30.0%) |
| Jun 2016 | - | -$1.04 M(+26.5%) | -$3.36 M(+44.8%) |
| Mar 2016 | - | -$822.00 K(-2.5%) | -$2.32 M(+54.8%) |
| Dec 2015 | - | -$843.00 K(+28.1%) | -$1.50 M(+128.1%) |
| Sep 2015 | - | -$658.00 K | -$658.00 K |
FAQ
- What is Mustang Bio annual EBITDA?
- What is the all time high annual EBITDA for Mustang Bio?
- What is Mustang Bio annual EBITDA year-on-year change?
- What is Mustang Bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for Mustang Bio?
- What is Mustang Bio quarterly EBITDA year-on-year change?
- What is Mustang Bio TTM EBITDA?
- What is the all time high TTM EBITDA for Mustang Bio?
- What is Mustang Bio TTM EBITDA year-on-year change?
What is Mustang Bio annual EBITDA?
The current annual EBITDA of MBIO is -$48.06 M
What is the all time high annual EBITDA for Mustang Bio?
Mustang Bio all-time high annual EBITDA is -$11.51 M
What is Mustang Bio annual EBITDA year-on-year change?
Over the past year, MBIO annual EBITDA has changed by +$23.07 M (+32.43%)
What is Mustang Bio quarterly EBITDA?
The current quarterly EBITDA of MBIO is -$1.36 M
What is the all time high quarterly EBITDA for Mustang Bio?
Mustang Bio all-time high quarterly EBITDA is -$658.00 K
What is Mustang Bio quarterly EBITDA year-on-year change?
Over the past year, MBIO quarterly EBITDA has changed by $0.00 (0.00%)
What is Mustang Bio TTM EBITDA?
The current TTM EBITDA of MBIO is -$22.30 M
What is the all time high TTM EBITDA for Mustang Bio?
Mustang Bio all-time high TTM EBITDA is -$658.00 K
What is Mustang Bio TTM EBITDA year-on-year change?
Over the past year, MBIO TTM EBITDA has changed by $0.00 (0.00%)